| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $497.0M | +25.7% |
| Cost of Revenue | $347.3M | +26.7% |
| Gross Profit | $149.7M | +23.3% |
| R&D Expense | $41.2M | +20.8% |
| SG&A Expense | $38.1M | +15.7% |
| Operating Income | -$3.0M | -128.7% |
| Pre-tax Income | -$1.3M | -112.6% |
| Income Tax | -$795K | -174.6% |
| Net Income | -$513K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.3M | -12.5% |
| Accounts Receivable | $67.8M | +54.3% |
| Current Assets | $229.0M | -10.7% |
| Total Assets | $461.5M | -2.4% |
| Current Liabilities | $51.5M | -30.8% |
| Total Liabilities | $64.4M | -25.9% |
| Stockholders' Equity | $397.2M | +2.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.9M | +1.9% |
| Capital Expenditures | $1.3M | +28.4% |
| Investing Cash Flow | -$34.6M | +55.6% |
| Financing Cash Flow | -$37.3M | -117.5% |
| Free Cash Flow | $18.6M | +0.5% |
| -105.5% |
| EPS (Basic) | $0.00 | -100.0% |
| EPS (Diluted) | $0.00 | -100.0% |